Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407017 · ClinicalTrials.gov registry record · Phase 4
Therapeutic Variables in Cataract Surgery
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00407017 is a Phase 4 study that has completed, run by Innovative Medical.
The verdict
NCT00407017, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
Interventions
- DRUG Moxifloxacin
- DRUG Gatifloxacin
- DRUG Pred Forte
- DRUG Nepafenac
- DRUG Ketorolac LS
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00407017
The ClinicalTrials.gov registry entry for NCT00407017 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Moxifloxacin is the first listed.
NCT00407017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00407017 about?
NCT00407017 is a clinical study titled "Therapeutic Variables in Cataract Surgery". The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
What is the current status of trial NCT00407017?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00407017?
The interventions under investigation include: Moxifloxacin (DRUG), Gatifloxacin (DRUG), Pred Forte (DRUG), Nepafenac (DRUG), Ketorolac LS (DRUG).
Who is sponsoring clinical trial NCT00407017?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.